Put Merck to work? [Video]
|Merck & Co is a multinational healthcare US company which is based in New Jersey. Originally founded in Germany Merck is known for its development of medicines, vaccines, and biological therapies. With Goldman Sachs raising its probability of the US economy entering a recession in the next 12 months by 10bps to 35% is it worth looking at Merck’s strong seasonals? Although the healthcare sector is not ‘recession proof’ the healthcare sector has a reputation for performing well during economic downturns.
The seasonals are certainly strong. Over the last 10 years between March 17 and June 9, Merck’s shares have risen by an average of over 6%. The winning percentage is also 100% and the maximum drawdown is just over 10%. So, is it time to put Merck to work?
Major trade risks: The major trade risk here is that an economic downturn also drags on Merck’s share price and/or some specific news hinders the share price.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.